Vanesa Vicens-Zygmunt

5PUBLICATIONS
33CO-AUTHORS
Predictive and prognostic markersCondensed matter characterisation technique developmentPacific Peoples theory of change models for healthFood properties (incl. characteristics and health benefits)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 26, 2026
Real-World Experience with Nintedanib in a Progressive Pulmonary Fibrosis Cohort.

|Apr 23, 2026
A prospective cohort study for characterization and predictive factors of long-term POST-COVID interstitial changes.

|Mar 28, 2025
Pirfenidone in post-COVID-19 pulmonary fibrosis (FIBRO-COVID): a phase 2 randomised clinical trial.

Guadalupe Bermudo-Peloche, Belén Del Rio, Vanesa Vicens-Zygmunt

|Oct 19, 2023
Gastrointestinal pirfenidone adverse events in idiopathic pulmonary fibrosis depending on diet: the MADIET clinical trial.

Maria Molina-Molina, Jessica Germaine Shull, Vanesa Vicens-Zygmunt

|Sep 13, 2018
Identification of MMP28 as a biomarker for the differential diagnosis of idiopathic pulmonary fibrosis.

Mariel Maldonado, Ivette Buendía-Roldán, Vanesa Vicens-Zygmunt

Pageof 1

Frequent Collaborators

3 joint publications

Jaume Bordas-Martinez

2 joint publications

Guadalupe Bermudo-Peloche

2 joint publications

Guillermo Suarez-Cuartin

2 joint publications

Claudia Valenzuela